The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
The Therapeutic Potential of Cannabis and Cannabinoids
Open accessAbstract
BACKGROUND: Cannabis-based medications have been a topic of intense study since the endogenous cannabinoid system was discovered two decades ago. In 2011, for the first time, a cannabis extract was approved for clinical use in Germany. METHODS: Selective literature review. RESULTS: Cannabis-based medications exert their effects mainly through the activation of cannabinoid receptors (CB1 and CB2). More than 100 controlled clinical trials of cannabinoids or whole-plant preparations for various indications have been conducted since 1975. The findings of these trials have led to the approval of cannabis-based medicines (dronabinol, nabilone, and a cannabis extract [THC:CBD=1:1]) in several countries. In Germany, a cannabis extract was approved in 2011 for the treatment of moderate to severe refractory spasticity in multiple sclerosis. It is commonly used off label for the treatment of anorexia, nausea, and neuropathic pain. Patients can also apply for government permission to buy medicinal cannabis flowers for self-treatment under medical supervision. The most common side effects of cannabinoids are tiredness and dizziness (in more than 10% of patients), psychological effects, and dry mouth. Tolerance to these side effects nearly always develops within a short time. Withdrawal symptoms are hardly ever a problem in the therapeutic setting. CONCLUSION: There is now clear evidence that cannabinoids are useful for the treatment of various medical conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,393
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., Greasley, P. J., Hansen, H. S., Kunos, G., Mackie, K., et al. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003004 · Cited by 1,605
Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., & Thompson, A. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14738-1 · Cited by 827
American Society of Clinical Oncology Guideline for Antiemetics in Oncology: Update 2006
Kris, M. G., Hesketh, P. J., Somerfield, M. R., Feyer, P., Clark-Snow, R., Koeller, J. M., Morrow, G. R., Chinnery, L. W., Chesney, M. J., Gralla, R. J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.9591 · Cited by 740
Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis
Rog, D. J., Nurmikko, T. J., Friede, T., & Young, C. A. (2005) · Neurology · doi:10.1212/01.wnl.0000176753.45410.8b · Cited by 679
Johnson, J. R., Burnell-Nugent, M., Lossignol, D., Ganae-Motan, E. D., Potts, R., & Fallon, M. T. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2009.06.008 · Cited by 622
Dose-related neurocognitive effects of marijuana use
Bolla, K. I., Brown, K., Eldreth, D., Tate, K., & Cadet, J. L. (2002) · Neurology · doi:10.1212/01.wnl.0000031422.66442.49 · Cited by 608
Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial
Abrams, D. I., Jay, C. A., Shade, S. B., Vizoso, H., Reda, H., Press, S., Kelly, M. E., Rowbotham, M. C., & Petersen, K. L. (2007) · Neurology · doi:10.1212/01.wnl.0000253187.66183.9c · Cited by 598
Wade, D. T., Makela, P., Robson, P., House, H., & Bateman, C. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1082oa · Cited by 589
Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587
Jatoi, A., Windschitl, H. E., Loprinzi, C. L., Sloan, J. A., Dakhil, S. R., Mailliard, J. A., Pundaleeka, S., Kardinal, C. G., Fitch, T. R., Krook, J. E., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.2.567 · Cited by 543
Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS
Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., Lefkowitz, L., Plasse, T. F., & Shepard, K. V. (1995) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(94)00117-4 · Cited by 504
Svendsen, K. B., Jensen, T. S., & Bach, F. W. (2004) · BMJ · doi:10.1136/bmj.38149.566979.ae · Cited by 500
Novotna, A., Mares, J., Ratcliffe, S., Novakova, I., Vachova, M., Zapletalova, O., Gasperini, C., Pozzilli, C., Cefaro, L., Comi, G., et al. (2011) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03328.x · Cited by 475
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ellis, R. J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., Bentley, H., & Atkinson, J. H. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.120 · Cited by 461
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial
Ware, M. A., Wang, T., Shapiro, S., Robinson, A., Ducruet, T., Huynh, T., Gamsa, A., Bennett, G. J., & Collet, J.-P. (2010) · Canadian Medical Association Journal · doi:10.1503/cmaj.091414 · Cited by 450
Wade, D. T., Robson, P., House, H., Makela, P., & Aram, J. (2003) · Clinical Rehabilitation · doi:10.1191/0269215503cr581oa · Cited by 441
Emerging strategies for exploiting cannabinoid receptor agonists as medicines
Pertwee, R. G. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00048.x · Cited by 436
Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006) · Rheumatology · doi:10.1093/rheumatology/kei183 · Cited by 433
Nurmikko, T. J., Serpell, M. G., Hoggart, B., Toomey, P. J., Morlion, B. J., & Haines, D. (2007) · Pain · doi:10.1016/j.pain.2007.08.028 · Cited by 431
Strasser, F., Luftner, D., Possinger, K., Ernst, G., Ruhstaller, T., Meissner, W., Ko, Y.-D., Schnelle, M., Reif, M., & Cerny, T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.1847 · Cited by 413
Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study
GRANT, I., GONZALEZ, R., CAREY, C. L., NATARAJAN, L., & WOLFSON, T. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703950016 · Cited by 411
Nabilone for the treatment of pain in fibromyalgia.
Skrabek, R. Q., Galimova, L., Ethans, K., & Perry, D. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.09.002 · Cited by 384
Randomized controlled trial of cannabis‐based medicine in spasticity caused by multiple sclerosis
Collin, C., Davies, P., Mutiboko, I. K., Ratcliffe, S., & for the Sativex Spasticity in MS Study Group (2007) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01639.x · Cited by 379
The analgesic properties of delta‐9‐tetrahydrocannabinol and codeine
Noyes, R., Brunk, S. F., Avery, D. H., & Canter, A. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197518184 · Cited by 378
Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer Chemotherapy
Sallan, S. E., Zinberg, N. E., & Frei, E. (1975) · New England Journal of Medicine · doi:10.1056/nejm197510162931603 · Cited by 364
Berman, J. S., Symonds, C., & Birch, R. (2004) · Pain · doi:10.1016/j.pain.2004.09.013 · Cited by 362
Karst, M., Salim, K., Burstein, S., Conrad, I., Hoy, L., & Schneider, U. (2003) · JAMA · doi:10.1001/jama.290.13.1757 · Cited by 340
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
Zajicek, J. P. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.070136 · Cited by 335
A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain
Wilsey, B., Marcotte, T., Tsodikov, A., Millman, J., Bentley, H., Gouaux, B., & Fishman, S. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.12.010 · Cited by 327
The Effects of Nabilone on Sleep in Fibromyalgia: Results of a Randomized Controlled Trial
Ware, M. A., Fitzcharles, M.-A., Joseph, L., & Shir, Y. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181c76f70 · Cited by 324
Notcutt, W., Price, M., Miller, R., Newport, S., Phillips, C., Simmons, S., & Sansom, C. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03674.x · Cited by 305
Wade, D. T., Makela, P. M., House, H., Bateman, C., & Robson, P. (2006) · Multiple Sclerosis Journal · doi:10.1177/1352458505070618 · Cited by 285
Analgesic Effect of Delta‐9‐Tetrahydrocannabinol
NOYES, R., BRUNK, S. F., BARAM, D. A., & CANTER, A. (1975) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1975.tb02348.x · Cited by 273
Muller-Vahl, K. R., Schneider, U., Prevedel, H., Theloe, K., Kolbe, H., Daldrup, T., & Emrich, H. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0417 · Cited by 270
CLINICAL STUDIES OF CANNABIS TOLERANCE AND DEPENDENCE*
Jones, R. T., Benowitz, N., & Bachman, J. (1976) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1976.tb49901.x · Cited by 270
Vaney, C., Heinzel-Gutenbrunner, M., Jobin, P., Tschopp, F., Gattlen, B., Hagen, U., Schnelle, M., & Reif, M. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1048oa · Cited by 262
Sallan, S. E., Cronin, C., Zelen, M., & Zinberg, N. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198001173020302 · Cited by 261
CHANG, A. E., SHILING, D. J., STILLMAN, R. C., GOLDBERG, N. H., SEIPP, C. A., BAROFSKY, I., SIMON, R. M., & ROSENBERG, S. A. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-6-819 · Cited by 259
Efficacy of Dronabinol as an Adjuvant Treatment for Chronic Pain Patients on Opioid Therapy
Narang, S., Gibson, D., Wasan, A. D., Ross, E. L., Michna, E., Nedeljkovic, S. S., & Jamison, R. N. (2008) · The Journal of Pain · doi:10.1016/j.jpain.2007.10.018 · Cited by 257
Treatment of Tourette's Syndrome with Δ9-Tetrahydrocannabinol (THC): A Randomized Crossover Trial
Müller-Vahl, K., Schneider, U., Koblenz, A., Jöbges, M., Kolbe, H., Daldrup, T., & Emrich, H. (2002) · Pharmacopsychiatry · doi:10.1055/s-2002-25028 · Cited by 256
Self-citationO'Sullivan, S. E., & Kendall, D. A. (2010) · Immunobiology · doi:10.1016/j.imbio.2009.09.007 · Cited by 247
Brisbois, T. D., de Kock, I. H., Watanabe, S. M., Mirhosseini, M., Lamoureux, D. C., Chasen, M., MacDonald, N., Baracos, V. E., & Wismer, W. V. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq727 · Cited by 246
Abrams, D. I., Hilton, J. F., Leiser, R. J., Shade, S. B., Elbeik, T. A., Aweeka, F. T., Benowitz, N. L., Bredt, B. M., Kosel, B., Aberg, J. A., et al. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-4-200308190-00008 · Cited by 238
Brady, C. M., DasGupta, R., Dalton, C., Wiseman, O. J., Berkley, K. J., & Fowler, C. J. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1063oa · Cited by 238
Herman, T. S., Einhorn, L. H., Jones, S. E., Nagy, C., Chester, A. B., Dean, J. C., Furnas, B., Williams, S. D., Leigh, S. A., Dorr, R. T., et al. (1979) · New England Journal of Medicine · doi:10.1056/nejm197906073002302 · Cited by 216
Meiri, E., Jhangiani, H., Vredenburgh, J. J., Barbato, L. M., Carter, F. J., Yang, H.-M., & Baranowski, V. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x167525 · Cited by 214
Freeman, R. M., Adekanmi, O., Waterfield, M. R., Waterfield, A. E., Wright, D., & Zajicek, J. (2006) · International Urogynecology Journal · doi:10.1007/s00192-006-0086-x · Cited by 209
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
Killestein, J., Hoogervorst, E. L. J., Reif, M., Kalkers, N. F., van Loenen, A. C., Staats, P. G. M., Gorter, R. W., Uitdehaag, B. M. J., & Polman, C. H. (2002) · Neurology · doi:10.1212/wnl.58.9.1404 · Cited by 209
Frank, B., Serpell, M. G., Hughes, J., Matthews, J. N. S., & Kapur, D. (2008) · BMJ · doi:10.1136/bmj.39429.619653.80 · Cited by 207
Beal, J. E., Olson, R., Lefkowitz, L., Laubenstein, L., Bellman, P., Yangco, B., Morales, J. O., Murphy, R., Powderly, W., Plasse, T. F., et al. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00038-9 · Cited by 206
FRYTAK, S., MOERTEL, C. G., O'FALLON, J. R., RUBIN, J., CREAGAN, E. T., O'CONNELL, M. J., SCHUTT, A. J., & SCHWARTAU, N. W. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-6-825 · Cited by 201
Daily Cannabis Use: A Novel Risk Factor of Steatosis Severity in Patients With Chronic Hepatitis C
Hézode, C., Zafrani, E. S., Roudot–Thoraval, F., Costentin, C., Hessami, A., Bouvier–Alias, M., Medkour, F., Pawlostky, J., Lotersztajn, S., & Mallat, A. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.039 · Cited by 190
Selvarajah, D., Gandhi, R., Emery, C. J., & Tesfaye, S. (2010) · Diabetes Care · doi:10.2337/dc09-1029 · Cited by 189
Dronabinol and Marijuana in HIV-Positive Marijuana Smokers: Caloric Intake, Mood, and Sleep
Haney, M., Gunderson, E. W., Rabkin, J., Hart, C. L., Vosburg, S. K., Comer, S. D., & Foltin, R. W. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31811ed205 · Cited by 184
Lack of analgesic efficacy of oral δ-9-tetrahydrocannabinol in postoperative pain
Buggy, D. J., Toogood, L., Maric, S., Sharpe, P., Lambert, D. G., & Rowbotham, D. J. (2003) · Pain · doi:10.1016/s0304-3959(03)00331-2 · Cited by 184
Safety, tolerability, and efficacy of orally administered cannabinoids in MS
Russo, E. B. (2003) · Neurology · doi:10.1212/wnl.60.4.729-a · Cited by 184
Vandrey, R. G., Budney, A. J., Hughes, J. R., & Liguori, A. (2008) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2007.06.010 · Cited by 182
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis
Kavia, R., De Ridder, D., Constantinescu, C., Stott, C., & Fowler, C. (2010) · Multiple Sclerosis Journal · doi:10.1177/1352458510378020 · Cited by 173
Wissel, J., Haydn, T., Müller, J., Brenneis, C., Berger, T., Poewe, W., & Schelosky, L. D. (2006) · Journal of Neurology · doi:10.1007/s00415-006-0218-8 · Cited by 171
Durán, M., Pérez, E., Abanades, S., Vidal, X., Saura, C., Majem, M., Arriola, E., Rabanal, M., Pastor, A., Farré, M., et al. (2010) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2010.03743.x · Cited by 166
Holdcroft, A., Maze, M., Doré, C., Tebbs, S., & Thompson, S. (2006) · Anesthesiology · doi:10.1097/00000542-200605000-00021 · Cited by 166
Delta-9-THC in the Treatment of Spasticity Associated with Multiple Sclerosis
Ungerleider, J. T., Andyrsiak, T., Fairbanks, L., Ellison, G. W., & Myers, L. W. (1988) · Advances in Alcohol & Substance Abuse · doi:10.1300/j251v07n01_04 · Cited by 165
Effects of nabilone, a synthetic cannabinoid, on postoperative pain
Beaulieu, P. (2006) · Canadian Journal of Anesthesia/Journal canadien d'anesthésie · doi:10.1007/bf03022793 · Cited by 161
Treatment of Human Spasticity with Δ9‐Tetrahydrocannabinol
Petro, D. J., & Ellenberger, C. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02621.x · Cited by 154
Evaluation of Intramuscular Levonantradol and Placebo in Acute Postoperative Pain
Jain, A. K., Ryan, J. R., McMahon, F. G., & Smith, G. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02610.x · Cited by 150
Timpone, J. G., Wright, D. J., Li, N., Egorin, M. J., Enama, M. E., Mayers, J., Galetto, G., & DATRI 004 STUDY GROUP (1997) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1997.13.305 · Cited by 133
Dronabinol and marijuana in HIV+ marijuana smokers: acute effects on caloric intake and mood
Haney, M., Rabkin, J., Gunderson, E., & Foltin, R. W. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2242-2 · Cited by 126
Ostenfeld, T., Price, J. A., Albanese, M., Bullman, J., Guillard, F., Meyer, I., Leeson, R., Costantin, C., Ziviani, L., Nocini, P. F., et al. (2011) · Clinical Journal of Pain · doi:10.1097/ajp.0b013e318219799a · Cited by 126
Berman, J. S., Lee, J., Cooper, M., Cannon, A., Sach, J., McKerral, S., Taggart, M., Symonds, C., Fishe, K., & Birch, R. (2003) · Anaesthesia · doi:10.1046/j.1365-2044.2003.03408_3.x · Cited by 122
Grotenhermen, F. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/156800705774322111 · Cited by 121
Self-citationEffect of Dronabinol on Nutritional Status in HIV Infection
Struwe, M. C. W., Kaempfer, S., Geiger, C. J., Pavia, A. T., Plasse, T. F., Shepard, K. V., Ries, K., & Evans, T. G. (1993) · Annals of Pharmacotherapy · doi:10.1177/106002809302700701 · Cited by 117
Lane, M., Vogel, C. L., Ferguson, J., Krasnow, S. H., Saiers, J. L., Hamm, J. T., Salva, K., Wiernik, P. H., Holroyde, C. P., Hammill, S., et al. (1991) · Journal of Pain and Symptom Management · doi:10.1016/0885-3924(91)90026-z · Cited by 112
Effect of Dronabinol on Central Neuropathic Pain After Spinal Cord Injury
Rintala, D. H., Fiess, R. N., Tan, G., Holmes, S. A., & Bruel, B. M. (2010) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0b013e3181f1c4ec · Cited by 108
Raft, D. D., Gregg, J. M., Ghia, J. N., & Harris, L. S. (1977) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt197721126 · Cited by 103
The Toxicology of Cannabis and Cannabis Prohibition
Grotenhermen, F. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790151 · Cited by 103
Self-citationThe effects of cannabinoids on the pharmacokinetics of indinavir and nelfinavir
Kosel, B. W., Aweeka, F. T., Benowitz, N. L., Shade, S. B., Hilton, J. F., Lizak, P. S., & Abrams, D. I. (2002) · AIDS · doi:10.1097/00002030-200203080-00005 · Cited by 101
Nabilone: an alternative antiemetic for cancer chemotherapy.
Dalzell, A. M., Bartlett, H., & Lilleyman, J. S. (1986) · Archives of Disease in Childhood · doi:10.1136/adc.61.5.502 · Cited by 98
AMELIORATION OF CANCER CHEMOTHERAPY‐INDUCED NAUSEA AND VOMITING BY DELTA‐9‐TETRAHYDRO‐CANNABINOL
Ekert, H., Waters, K., Jurk, I., Mobilia, J., & Loughnan, P. M. (1979) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1979.tb127271.x · Cited by 97
Pinsger, M., Schimetta, W., Volc, D., Hiermann, E., Riederer, F., & Pölz, W. (2006) · Wiener klinische Wochenschrift · doi:10.1007/s00508-006-0611-4 · Cited by 96
Chan, H. S. L., Correia, J., & MacLeod, S. M. (1987) · PEDIATRICS · doi:10.1542/peds.79.6.946 · Cited by 95
Shiling, D. J., Stillman, R. C., Chang, A. E., Goldberg, N. H., Seipp, C. A., Barofsky, I., & Rosenberg, S. A. (1981) · Cancer · Cited by 94
Nabilone: An Effective Antiemetic in Patients Receiving Cancer Chemotherapy
Einhorn, L. H., Nagy, C., Furnas, B., & Williams, S. D. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02576.x · Cited by 91
Orr, L. E. (1980) · Archives of Internal Medicine · doi:10.1001/archinte.140.11.1431 · Cited by 91
Mechoulam, R. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7358-x · Cited by 90
Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy
Ahmedzai, S. H., Carlyle, D., Calder, I. T., & Moran, F. (1983) · British Journal of Cancer · doi:10.1038/bjc.1983.247 · Cited by 88
Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain
Staquet, M. J., Gantt, C., & Machin, D. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978234397 · Cited by 87
Gralla, R. J., Tyson, L. B., Bordin, L. A., Clark, R. A., Kelsen, D. P., Kris, M. G., Kalman, L., & Groshen, S. G. (1984) · PubMed · Cited by 87
Medicinal Cannabis Does Not Influence the Clinical Pharmacokinetics of Irinotecan and Docetaxel
Engels, F. K., de Jong, F. A., Sparreboom, A., Mathôt, R. A. A., Loos, W. J., Kitzen, J. J. E. M., de Bruijn, P., Verweij, J., & Mathijssen, R. H. J. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-291 · Cited by 80
Bedi, G., Foltin, R. W., Gunderson, E. W., Rabkin, J. G., Hart, C. L., Comer, S. D., Vosburg, S. K., & Haney, M. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1995-4 · Cited by 76
Efficacy of tetrahydrocannabinol in patients refractory to standard antiemetic therapy
McCabe, M., Smith, F. P., Macdonald, J. S., Woolley, P. V., Goldberg, D., & Schein, P. S. (1988) · Investigational New Drugs · doi:10.1007/bf00175407 · Cited by 70
The treatment of spasticity with Δ9-tetrahydrocannabinol in persons with spinal cord injury
Hagenbach, U., Luz, S., Ghafoor, N., Berger, J. M., Grotenhermen, F., Brenneisen, R., & Mäder, M. (2007) · Spinal Cord · doi:10.1038/sj.sc.3101982 · Cited by 70
Self-citationSTEELE, N. E., Gralla, R. J., Dw, B., & Cw, Y. (1980) · PubMed · Cited by 70
Pooyania, S., Ethans, K., Szturm, T., Casey, A., & Perry, D. (2010) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2009.12.025 · Cited by 64
Conte, A., Bettolo, C. M., Onesti, E., Frasca, V., Iacovelli, E., Gilio, F., Giacomelli, E., Gabriele, M., Aragona, M., Tomassini, V., et al. (2009) · European Journal of Pain · doi:10.1016/j.ejpain.2008.05.014 · Cited by 62
Synthetic Δ-9-Tetrahydrocannabinol (Dronabinol) Can Improve the Symptoms of Schizophrenia
SCHWARCZ, G., Karajgi, B. M., & McCarthy, R. H. (2009) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e3181a6bc3b · Cited by 60
Pomeroy, M., FENNELLY, J. J., & Towers, M. J. (1986) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00256701 · Cited by 59
Cunningham, D., Bradley, C. J., Forrest, G. J., Hutcheon, A. W., Adams, L., Sneddon, M., Harding, M., Kerr, D., Soukop, M., & Kaye, S. B. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90300-8 · Cited by 58
Comparative Trial of the Antiemetic Effects of THC and Haloperidol
Neidhart, J. A., Gagen, M. M., Wilson, H. E., & Young, D. C. (1981) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1981.tb02571.x · Cited by 56
Johansson, R. T., Kilkku, P., & Groenroos, M. (1982) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(82)80032-7 · Cited by 54
A cross-over comparison of nabilone and prochlorperazine for emesis induced by cancer chemotherapy
Niiranen, A., & Mattson, K. V. (1985) · American Journal of Clinical Oncology · doi:10.1097/00000421-198508000-00013 · Cited by 54
Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis
Centonze, D., Mori, F., Koch, G., Buttari, F., Codecà, C., Rossi, S., Cencioni, M. T., Bari, M., Fiore, S., Bernardi, G., et al. (2009) · Neurological Sciences · doi:10.1007/s10072-009-0136-5 · Cited by 51
Effect of benzopyranoperidine, a Δ‐9‐THC congener, on pain
Jochimsen, P. R., Lawton, R. L., VerSteeg, K., & Noyes, R. (1978) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1978242223 · Cited by 50
Jones, S. E., Durant, J. R., Greco, F. A., & Robertone, A. B. (1982) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(82)80035-2 · Cited by 47
Crawford, S. M., & Buckman, R. A. (1986) · Medical Oncology and Tumor Pharmacotherapy · doi:10.1007/bf02934575 · Cited by 46
Pinsger, M., Schimetta, W., Volc, D., Hiermann, E., Riederer, F., & Pölz, W. (2006) · European Journal of Pain · doi:10.1016/s1090-3801(06)60627-7 · Cited by 43
Nelemans, J. K., Neleman, F. A., Meuwissen, O. J., & Maes, R. A. A. (1979) · PubMed · Cited by 43
Seeling, W., Kneer, L., Büchele, B., Gschwend, J. E., Maier, L., Nett, C., Simmet, T., Steffen, P., Schneider, M., & Rockemann, M. (2006) · Der Anaesthesist · doi:10.1007/s00101-005-0963-6 · Cited by 42
Double-blind, randomized, crossover trial of nabilone vs. placebo in cancer chemotherapy
Wada, J. K., Bogdon, D. L., Gunnell, J. C., Hum, G. J., Gota, C. H., & Rieth, T. E. (1982) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(82)80034-0 · Cited by 42
Meyer, J. S., & Connor, R. E. (1982) · Cancer · doi:10.1002/1097-0142(19820815)50:4<636::aid-cncr2820500404>3.0.co;2-4 · Cited by 41
Niederle, N., Schütte, J., & Schmidt, C. G. (1986) · Journal of Molecular Medicine · doi:10.1007/bf01728184 · Cited by 41
Colls, B. M., Ferry, D. G., Gray, A. J., Vj, H., & McQueen, E. G. (1980) · PubMed · Cited by 41
Nabilone vs. placebo in the treatment of chemotherapy-induced nausea and vomiting in cancer patients
Levitt, M. (1982) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(82)80036-4 · Cited by 34
THC or Compazine® for the cancer chemotherapy patient—the UCLA study
Ungerleider, J. T., Fairbanks, L. A., Andrysiak, T., Sarna, G. P., Goodnight, J. E., & Jamison, K. R. (1985) · American Journal of Clinical Oncology · doi:10.1097/00000421-198504000-00006 · Cited by 31
Hutcheon, A. W., Palmer, J. B. D., Soukop, M., Cunningham, D., McArdle, C. S., Welsh, J., Stuart, F., Sangster, G., Kaye, S. B., Charlton, D., et al. (1983) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(83)90032-9 · Cited by 30
Kurzthaler, I., Bodner, T., Kemmler, G., Entner, T., Wissel, J. H., Berger, T., & Fleischhacker, W. W. (2005) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.688 · Cited by 25
Citron, M. L., Ts, H., Vreeland, F., Krasnow, S. H., Fossieck, B. E., Harwood, S., Franklin, R., & Mh, C. (1985) · PubMed · Cited by 23
Stambaugh, J. E., McAdams, J., & Vreeland, F. (1984) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1984.tb02756.x · Cited by 22
George, M., Mh, P., Thuaire, M., Kramar, A., & Jp, W. (1983) · PubMed · Cited by 18
Biological aspects of cannabis use.
Stefanis, C. N. (1978) · PubMed · Cited by 15
Evaluation of herbal cannabis characteristics by medical users: a randomized trial.
Ware, M. A., Ducruet, T., & Robinson, A. R. (2006) · Harm Reduction Journal · doi:10.1186/1477-7517-3-32 · Cited by 14
Higi, M., Niederle, N., Bremer, K., Schmitt, G., Schmidt, C. G., & Seeber, S. (2008) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-2008-1070107 · Cited by 11
Tetrahydrocannabinol zur Therapie chronischer Schmerzen
Elsner, F., Radbruch, L., & Sabatowski, R. (2001) · Der Schmerz · doi:10.1007/s004820170024 · Cited by 11
Interactions of Marihuana and THC with Other Drugs
Hollister, L. E. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_27 · Cited by 5
(1997) · doi:10.1002/(sici)1099-1166(199709)12:9<913::aid-gps663>3.0.co;2-d
Cited by
Evolution and classification of Cannabis sativa (marijuana, hemp) in relation to human utilization.
Small, E. (2015) · The Botanical Review · doi:10.1007/s12229-015-9157-3 · Cited by 461
Plant derived substances with anti-cancer activity: from folklore to practice
Fridlender, M., Kapulnik, Y., & Koltai, H. (2015) · Frontiers in Plant Science · doi:10.3389/fpls.2015.00799 · Cited by 415
Cannabinoids and Cytochrome P450 Interactions
Zendulka, O., Dovrtělová, G., Nosková, K., Turjap, M., Šulcová, A., Hanuš, L., & Juřica, J. (2016) · Current Drug Metabolism · doi:10.2174/1389200217666151210142051 · Cited by 291
Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature.
Michaels, T. I., Purdon, J., Collins, A., & Williams, M. T. (2018) · BMC Psychiatry · doi:10.1186/s12888-018-1824-6 · Cited by 265
CB2 Cannabinoid Receptors as a Therapeutic Target—What Does the Future Hold?
Dhopeshwarkar, A., & Mackie, K. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.094649 · Cited by 257
Metadata
- Authors
- Grotenhermen, F., & Müller-Vahl, K.
- Venue
- Deutsches Ärzteblatt international
- Publisher
- Deutscher Arzte-Verlag GmbH
- Published
- 2012-07-23
- Volume
- 109
- Issue
- 29-30
- Pages
- 495-501
- ISSN
- 1866-0452 (ISSN-L)
- OpenAlex
- W159022574
- Cited by
- 307
- References
- 126
- FWCI
- 10.53
- Type
- journal article
- Language
- de
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.